Nonetheless, due to the limitations inherent in the present proof-of-concept study, further research is essential to clarify the role of IF1 in guiding pro-inflammatory responses against infection and anti-tumor immunity as well as its potential as a target for therapy. Here, ATP5IF1 is linked to neoplasm.